Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Zoonotic Implications
Introduction
Leptospirosis is a globally distributed zoonotic disease caused by pathogenic spirochetes of the genus Leptospira. In dogs, the disease presents a significant diagnostic and therapeutic challenge due to its variable clinical manifestations and the potential for severe, life-threatening organ dysfunction [1, 2]. The infection is acquired through direct or indirect contact with urine from infected reservoir hosts, with the spirochetes penetrating mucous membranes or abraded skin [3, 4]. Once in the bloodstream, leptospires disseminate to multiple organs, particularly the kidneys and liver, where they cause tubulointerstitial nephritis and hepatocellular damage [5, 6]. The re-emergence of leptospirosis in many regions, driven by urbanization, climate change, and shifting serovar distributions, has renewed focus on accurate diagnosis and the zoonotic implications for owners [7, 8].
Clinical Signs
The clinical presentation of canine leptospirosis ranges from subclinical infection to fulminant multisystemic disease. The incubation period is typically 5 to 14 days [9]. Common clinical signs include lethargy, anorexia, vomiting, abdominal pain, polydipsia, and polyuria [10, 11]. Fever is often present in the acute phase but may be absent by the time of presentation [12].
Renal involvement is a hallmark of the disease. Acute kidney injury (AKI) manifests as azotemia, isosthenuria, and proteinuria [13, 14]. Hepatic involvement leads to icterus, elevated liver enzyme activities (alanine aminotransferase, alkaline phosphatase), and hyperbilirubinemia [15, 16]. A purely hepatic form without significant azotemia has been described in some populations [17].
Pulmonary involvement, termed leptospiral pulmonary hemorrhage syndrome (LPHS), is an increasingly recognized severe manifestation characterized by respiratory distress, hemoptysis, and radiographic evidence of alveolar infiltrates [18, 19]. LPHS carries a high case fatality rate and is often associated with multiple organ dysfunction syndrome [20, 21].
Other clinical findings include myalgia, stiff gait, hemorrhagic diathesis (petechiae, epistaxis), and gastrointestinal signs such as diarrhea [22, 23]. Chronic infection can result in a carrier state with persistent leptospiruria without overt clinical signs [24, 25].
Diagnosis
Definitive diagnosis of canine leptospirosis relies on a combination of serological and molecular methods, supported by clinicopathological data.
Serological Methods
The microscopic agglutination test (MAT) remains the reference standard for serodiagnosis [26, 27]. MAT detects antibodies against a panel of live leptospiral serovars. A single titer of 1:800 or greater in a dog with compatible clinical signs is considered supportive of acute infection, while a four-fold rise in paired acute and convalescent sera confirms seroconversion [28, 29]. However, MAT has limitations: it lacks sensitivity early in the disease before antibody production, it can be negative in immunocompromised animals, and prior vaccination may produce cross-reactive titers [30, 31].
Enzyme-linked immunosorbent assays (ELISAs) targeting IgM or IgG antibodies offer improved early sensitivity. IgM detection is particularly useful for identifying acute infections [32, 33]. Commercial ELISA kits using whole-cell or outer membrane protein antigens have been developed, but their performance varies with the local serovar composition [34, 35].
Rapid point-of-care immunochromatographic tests for IgM detection provide a convenient in-clinic screening tool. These lateral flow assays have demonstrated sensitivities of 75-98% and specificities above 90% when compared to MAT [36, 37]. Positive results in a dog with suggestive clinical signs strongly indicate acute leptospirosis, but negative results do not rule out infection and should prompt confirmatory testing [38].
Molecular Methods
Polymerase chain reaction (PCR) assays targeting conserved genes such as LipL32, 16S rRNA, or secY enable direct detection of leptospiral DNA in blood, urine, or tissue samples [39, 40]. Real-time PCR (qPCR) offers high sensitivity and specificity, and can detect infection before seroconversion [41, 42]. Blood PCR is most sensitive during the first week of illness (leptospiremic phase), while urine PCR is valuable for detecting renal shedding in the second week and beyond [43, 44]. A positive urine PCR in a dog with negative serology may indicate a carrier state [45].
Quantitative PCR can also provide an estimate of bacterial load, which may correlate with disease severity [46]. Multiplex PCR panels that include other pathogens are available for differential diagnosis of febrile illness [47].
Clinicopathological and Biomarker Aids
Routine hematology and serum biochemistry provide supportive evidence. Common findings include thrombocytopenia, leukocytosis, azotemia, hyperbilirubinemia, and elevated liver enzymes [48, 49]. Urinalysis may reveal proteinuria, glucosuria, and granular casts [50].
Novel biomarkers for early detection of renal injury include urinary kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). These markers can detect tubular damage before a rise in serum creatinine, facilitating earlier intervention [51, 52]. The neutrophil-to-lymphocyte ratio (NLR) has been identified as an independent predictor of leptospirosis-related death in dogs [53].
Machine learning algorithms incorporating clinical variables from the first day of hospitalization have been developed to aid early diagnosis. These models have shown 100% sensitivity and >90% specificity in predicting leptospirosis, outperforming acute serology alone [54].
Diagnostic Workflow
The following Mermaid diagram outlines a recommended diagnostic algorithm for suspected canine leptospirosis.
flowchart TD
A[Clinical suspicion: fever, AKI, icterus, respiratory signs], > B{Point-of-care IgM test}
B, >|Positive| C[High probability: start treatment, confirm with MAT/PCR]
B, >|Negative| D{Blood qPCR}
D, >|Positive| C
D, >|Negative| E{Urine qPCR}
E, >|Positive| C
E, >|Negative| F{MAT on acute serum}
F, >|Titer >= 1:800| C
F, >|Titer < 1:800| G[Repeat MAT in 2-4 weeks]
G, >|Four-fold rise| C
G, >|No rise| H[Alternative diagnosis]
Treatment
The goals of treatment are to eliminate the infection, provide supportive care for organ dysfunction, and prevent zoonotic transmission. Antimicrobial therapy should be initiated as soon as leptospirosis is suspected, without waiting for confirmatory test results [55].
Antimicrobial Agents
Doxycycline is the drug of choice for both the acute phase and elimination of the renal carrier state. The recommended dose is 5 mg/kg orally every 12 hours for 14 days [56, 57]. For dogs unable to tolerate oral medication, intravenous ampicillin (20 mg/kg every 6 hours) or penicillin G (25,000-40,000 U/kg every 12 hours) can be used initially, followed by a course of doxycycline [58].
Fluoroquinolones such as enrofloxacin have shown efficacy in clinical trials, with a 10 mg/kg/day regimen for 10 days achieving PCR negativity in urine [59]. However, doxycycline remains the preferred agent due to its superior activity against the carrier state.
Supportive Care
Aggressive fluid therapy is essential for managing AKI, but care must be taken to avoid fluid overload, especially in oliguric or anuric patients [60]. Diuretics (furosemide, mannitol) may be used to maintain urine output. In severe AKI, renal replacement therapy (hemodialysis or hemofiltration) can be life-saving. Survival rates of 73% have been reported in dogs receiving extracorporeal renal replacement therapy for leptospirosis-associated AKI [61].
Hepatic support includes hepatoprotectants (S-adenosylmethionine, silymarin), vitamin K supplementation for coagulopathy, and management of hyperbilirubinemia [62]. For LPHS, oxygen therapy, mechanical ventilation, and careful fluid management are critical. Vasopressors may be required for hemodynamic support [63].
Zoonotic Implications and One Health
Leptospirosis is a zoonotic disease of major public health concern. Dogs can serve as sentinels and potential sources of infection for humans [64, 65]. Infected dogs shed leptospires in urine, contaminating the environment. The bacteria can survive for weeks in moist soil, water, and mud [66].
Human infection occurs through contact with contaminated water or soil, or directly with infected animal urine. Occupations at risk include veterinarians, kennel workers, and pet owners [67, 68]. The clinical presentation in humans ranges from mild flu-like illness to severe Weil's disease with jaundice, renal failure, and pulmonary hemorrhage [69].
A One Health approach integrating human, animal, and environmental surveillance is essential for effective control. Dogs can act as environmental sentinels; seroprevalence surveys in canine populations can identify areas of high risk for human infection [70, 71]. Public health measures include vaccination of dogs, rodent control, avoidance of stagnant water, and education of owners about the zoonotic risk [72, 73].
Prevention
Vaccination is the cornerstone of prevention. Modern quadrivalent vaccines include serogroups Canicola, Icterohaemorrhagiae, Grippotyphosa, and Australis, providing broader coverage than older bivalent vaccines [74, 75]. Vaccination reduces the severity of disease and decreases renal shedding, but does not completely prevent infection or carrier status [76, 77]. Annual booster vaccination is recommended for dogs at risk.
Environmental management includes preventing access to rodent-infested areas, removing standing water, and using disinfectants (e.g., bleach, quaternary ammonium compounds) to clean contaminated surfaces [78]. Owners should be advised to wear gloves when handling urine or cleaning areas where infected dogs have urinated.
Conclusion
Canine leptospirosis remains a diagnostic and therapeutic challenge with significant zoonotic implications. Early recognition of clinical signs, combined with appropriate use of serological and molecular diagnostic tests, is critical for improving outcomes. The integration of machine learning tools and novel biomarkers may further enhance early detection. A One Health perspective that includes vaccination, environmental control, and owner education is essential for reducing the burden of this re-emerging zoonosis.
References
[1] Sykes JE, Francey T, Schuller S, et al. Updated ACVIM consensus statement on leptospirosis in dogs. Journal of Veterinary Internal Medicine. 2023. https://www.semanticscholar.org/paper/ac87187b34fd6d4a9722f8f3704697d853567655
[2] Andrade-Silveira E, Ortega-Pacheco A, Jiménez-Coello M, et al. Review of leptospirosis in dogs from Mexico: Epidemiology, diagnosis, prevention, and treatment. Veterinary World. 2024. https://www.semanticscholar.org/paper/0cab1e69443aa8229505e3bee15f48afa4aaf6ff
[3] Tansakul M, Sawangjai P, Bunsupawong P, et al. Survival outcomes, low awareness, and the challenge of neglected leptospirosis in dogs. Open Veterinary Journal. 2024. https://www.semanticscholar.org/paper/a428b273e4d4f89c07e530683879c24d9c63a7df
[4] Suzuki R, Suzuki S, Sato OS, et al. Bacteriological and Serological Investigation of Leptospirosis in Dogs and Pigs in Palau. American Journal of Tropical Medicine and Hygiene. 2024. https://www.semanticscholar.org/paper/9a45d3bd3d6828de5cb2656202d777da063b75bf
[5] Sarangi S, Bharathi M, Madhanmohan M, et al. Occurrence of leptospirosis in dogs with renal and/or hepatic disease in Chennai, India. Indian Journal of Animal Health. 2024. https://www.semanticscholar.org/paper/4a061dcf1ddc0989baea453d2fa964e7cdae1e2e
[6] Wilson S, Shyma V, Tresamol P, et al. Haemato-biochemical alterations of clinical leptospirosis in dogs. Journal of Veterinary and Animal Sciences. 2026. https://www.semanticscholar.org/paper/15fead6d01a04ea49cfb8bd503af20938d738f82
[7] Hilbe M, Posthaus H, Paternoster G, et al. Exudative glomerulonephritis associated with acute leptospirosis in dogs. Veterinary Pathology-Supplement. 2023. https://www.semanticscholar.org/paper/312fef149de7d2bb102ce9bdbd70562286905401
[8] Reagan K, Deng S, Sheng J, et al. Use of machine-learning algorithms to aid in the early detection of leptospirosis in dogs. Journal of Veterinary Diagnostic Investigation. 2022. https://www.semanticscholar.org/paper/260d5ca33f5968826d13ab8249e86dd5442fd750
[9] Pinheiro T, Silva GM, Monteiro GDF, et al. Insights on seroprevalence of leptospirosis in dogs and cats from people with animal hoarding disorder profile in a semiarid region of Brazil. Ciência Rural. 2022. https://www.semanticscholar.org/paper/1f8afdb6a9d88649de3e06f8b6f565fc5d5f9259
[10] Taylor C, O'Neill D, Catchpole B, et al. Incidence and demographic risk factors for leptospirosis in dogs in the UK. The Veterinary Record. 2021. https://www.semanticscholar.org/paper/5d154ce5867605ed4282e5057f89eec1d13f142f
[11] Rahman MSA, Khor KH, Khairani-Bejo S, et al. Risk and Predictive Factors of Leptospirosis in Dogs Diagnosed with Kidney and/or Liver Disease in Selangor, Malaysia. Animals. 2021. https://www.semanticscholar.org/paper/e42f058b4c4e9d0d67b0f370367d50bc0efcdb54
[12] Paz LN, Dias CS, Almeida DS, et al. Multidisciplinary approach in the diagnosis of acute leptospirosis in dogs naturally infected by Leptospira interrogans serogroup Icterohaemorrhagiae: A prospective study. Comparative Immunology, Microbiology & Infectious Diseases. 2021. https://www.semanticscholar.org/paper/61d69fc5a5751192accf5c18f6bdbc7b5e3bcccb
[13] Francey T, Schweighauser A, Reber A, et al. Evaluation of changes in the epidemiology of leptospirosis in dogs after introduction of a quadrivalent antileptospiral vaccine in a highly endemic area. Journal of Veterinary Internal Medicine. 2020. https://www.semanticscholar.org/paper/894575f3d9e7e1b5a6e6bc83f8a96c283ef90887
[14] Schuller S, Francey T, Hartmann K, et al. European consensus statement on leptospirosis in dogs and cats. Journal of Small Animal Practice. 2015. https://www.semanticscholar.org/paper/9a85c60d5a25ae2a683188dad297470711cbfe06
[15] Troìa R, Balboni A, Zamagni S, et al. Prospective evaluation of rapid point-of-care tests for the diagnosis of acute leptospirosis in dogs. The Veterinary Journal. 2018. https://www.semanticscholar.org/paper/fe5724114a7a3a12da06939529a2f34ac394439e
[16] Lélu M, Munoz-Zanzi C, Higgins B, et al. Seroepidemiology of leptospirosis in dogs from rural and slum communities of Los Rios Region, Chile. BMC Veterinary Research. 2015. https://www.semanticscholar.org/paper/77455b80eb8ba4b6f537457ff00b1a911161b38e
[17] Murphy K. Leptospirosis in dogs and cats: new challenges from an old bacteria. A & A Practice. 2018. https://www.semanticscholar.org/paper/759ee3208c2bfef874bfd3c0b268d758132b1717
[18] Lizer JT, Grahlmann M, Hapke H, et al. Evaluation of a rapid IgM detection test for diagnosis of acute leptospirosis in dogs. The Veterinary Record. 2017. https://www.semanticscholar.org/paper/602ee85428535e1c7e3e9538a494a01bdd81ebab
[19] Raj J, Campbell R, Tappin S. Clinical findings in dogs diagnosed with leptospirosis in England. The Veterinary Record. 2021. https://www.semanticscholar.org/paper/05291d609c5b83cc5af8f6e15e3ba7a42de7919a
[20] Suepaul S. Leptospirosis in dogs, rodents and livestock in Trinidad. Journal. 2019. https://www.semanticscholar.org/paper/382b78a28e084c09d4a9d58f72db784e5b38fd20
[21] Murphy K. Dealing with leptospirosis in dogs. The Veterinary Record. 2018. https://www.semanticscholar.org/paper/0153d31dd7a2db90d43e8f0e7947b902fd1ea157
[22] Penna B, Marassi C, Libonati H, et al. Diagnostic accuracy of an in-house ELISA using the intermediate species Leptospira fainei as antigen for diagnosis of acute leptospirosis in dogs. Comparative Immunology, Microbiology & Infectious Diseases. 2017. https://www.semanticscholar.org/paper/c45f147436e595f64353c65a60739038396a8d19
[23] Kodjo A, Calleja C, Loenser M, et al. A Rapid In-Clinic Test Detects Acute Leptospirosis in Dogs with High Sensitivity and Specificity. BioMed Research International. 2016. https://www.semanticscholar.org/paper/0bf0f1f555f481cb6ab44eb1bc3341493418d6a9
[24] Heydari P, Tirbandpay M, Ghasemishayan R. Systematic review of the prevalence of environmental and host-related risk factors and the zoonotic potential of leptospirosis in domestic dogs in regions impacted by environmental changes. BMC Veterinary Research. 2025. https://www.semanticscholar.org/paper/dc259d1ba0a5e8cd83200c3f40e6178130655e49
[25] Bergmann M, Llewellyn JR, Hartmann K. [Diagnosis of leptospirosis in dogs]. Tierarztliche Praxis. Ausgabe K, Kleintiere/Heimtiere. 2017. https://www.semanticscholar.org/paper/eb44d39ad6c8e5ac37b0cbe0e3d8da0ba5cac25f
[26] Idress MA, Deepa P, Rathish R, et al. Diagnostic efficacy of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for early detection of acute kidney injury in dogs with leptospirosis or babesiosis. Veterinary research communications. 2024. https://www.semanticscholar.org/paper/9eaee10802454593270d74b9536601c250c1b94f
[27] Durán-Galea Á, Cristobal-Verdejo J, Macías-García B, et al. Determination of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in dogs with leptospirosis. Veterinary research communications. 2024. https://www.semanticscholar.org/paper/7518d7b62fa3aab0921d642fef27afc7bb32a6c6
[28] Ricardo T, Bazán Domínguez LR, Beltramini L, et al. Seroprevalence of Leptospira antibodies in dogs and cats from Santa Fe, a city in East-Central Argentina endemic for leptospirosis. Preventive Veterinary Medicine. 2024. https://www.semanticscholar.org/paper/685e98e2a8f08d6f7cd91a51bbc7d6b4601d98eb
[29] Koizumi N, Muto M, Akachi S, et al. Molecular and serological investigation of Leptospira and leptospirosis in dogs in Japan. Journal of Medical Microbiology. 2013. https://www.semanticscholar.org/paper/cc260d44cc67813592a75810c90ced55c20c5075
[30] Fraune C, Schweighauser A, Francey T. Evaluation of the diagnostic value of serologic microagglutination testing and a polymerase chain reaction assay for diagnosis of acute leptospirosis in dogs in a referral center. Journal of the American Veterinary Medical Association. 2013. https://www.semanticscholar.org/paper/77e5dcc05cd3a2ba859d0a7c4d28d38317d81615
[31] Paz G, Rocha KS, Lima MS, et al. Seroprevalence for brucellosis and leptospirosis in dogs from Belém and Castanhal, State of Pará, Brazil. Journal. 2015. https://www.semanticscholar.org/paper/502386c2bcdfff25071c4f856368b9cf39e6fb4e
[32] Murray MH, Buckley JY, Byers K, et al. Urban Rats (Rattus norvegicus) through a One Health Lens: Social and Ecological Factors Promote Opportunities for Urban Leptospirosis in Rats, Dogs, and People. One Health Cases. 2024. https://www.semanticscholar.org/paper/4842ca4f7dcbda779050213aa72fbf9ec7702f81
[33] Hennebelle J, Sykes J, Foley J. Risk Factors Associated with Leptospirosis in Dogs from Northern California: 2001-2010. Vector Borne and Zoonotic Diseases. 2014. https://www.semanticscholar.org/paper/9ec24fd3f03ce897d694c4cb26fddbda1af99ccd
[34] Turchenko O, Zon G. Leptospirosis in dogs in Sumy: epizootic monitoring, diagnostics and treatment. Journal. 2018. https://www.semanticscholar.org/paper/f54296c10c13726943bdbfbc7e55bf2fa5894ff8
[35] Carithers D, Loebach E, Williams T, et al. Field assessment of potential exposure of dogs to leptospirosis by measuring antibody titers in dogs: a multisite study in five geographic regions of the United States. Frontiers in Veterinary Science. 2024. https://www.semanticscholar.org/paper/a4d63c4f92defbd3759dbff7eeb5e51e2bc7e21e
[36] Suepaul S, Carrington CVF, Campbell M, et al. Seroepidemiology of leptospirosis in dogs and rats in Trinidad. Tropical biomedicine. 2014. https://www.semanticscholar.org/paper/a6f7561a097b4212b1fad2413f7372c5c69fb99c
[37] Azócar-Aedoa L, Smits HL, Monti G. Leptospirosis in dogs and cats: epidemiology, clinical disease, zoonotic implications and prevention. Journal. 2014. https://www.semanticscholar.org/paper/5f594425a21ae7de9556f15a06b0aaed7af4f59d
[38] Tangeman LE, Littman M. Clinicopathologic and atypical features of naturally occurring leptospirosis in dogs: 51 cases (2000-2010). Journal of the American Veterinary Medical Association. 2013. https://www.semanticscholar.org/paper/7f0f3bb9a1febcb7f1fd34ea6d41b5ab8ef52c45
[39] Andre-Fontaine G. Diagnosis algorithm for leptospirosis in dogs: disease and vaccination effects on the serological results. The Veterinary Record. 2013. https://www.semanticscholar.org/paper/12dbaf1e3c39562eb0d6aea87566cb2102517b47
[40] Idrees A, Deepa P, Vinodkumar K, et al. Assessment of acute kidney injury in dogs suffering from babesiosis and leptospirosis. Journal of Veterinary and Animal Sciences. 2023. https://www.semanticscholar.org/paper/4fb1fef4637d0ca4c3e19c5249bbe2b3d3ddb2ff
[41] Meeyam T, Tablerk P, Petchanok B, et al. Seroprevalence and risk factors associated with leptospi